Biogen Inc (NASDAQ: BIIB)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/01/2022
Closing price: 210.63
|Support price level:||$195.84|
|Resistance price level:||$214.09|
|Relative strength index (14-day RSI)||60.9|
- With a -39.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- BIIB is one of this month's top performers with a return of 6.1 percent, beating 90 percent of stocks in the S&P-100.
- Volatility is forecast to rise over the next month.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 11.0% in the next week.
- 26.5% in the next month.
- 105.6% in the next year.